Categories
Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-14)

In this article we will discuss Durvalumab (Warnings-14)

In this article, we will discuss Durvalumab (Warnings-14). So, let’s get started.

  • Immune-Mediated Endocrinopathies Adrenal Insufficiency
  • Durvalumab can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, initiate symptomatic treatment, including hormone replacement as clinically indicated. Withhold or permanently discontinue Durvalumab based on the severity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from PT Master Guide

Subscribe now to keep reading and get access to the full archive.

Continue reading